Open Access
EDITORIAL COMMENT
Re: Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma
Department of Urology
VA University Hospital,
New York University School of Medicine (NYU)
New York, NY
USA
Canadian Journal of Urology 2011, 18(1), 5536-5536.
Abstract
This article has no abstract.Cite This Article
APA Style
Djavan, B. (2011). Re: Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma. Canadian Journal of Urology, 18(1), 5536–5536.
Vancouver Style
Djavan B. Re: Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma. Can J Urology. 2011;18(1):5536–5536.
IEEE Style
B. Djavan, “Re: Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma,” Can. J. Urology, vol. 18, no. 1, pp. 5536–5536, 2011.

This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.